logo
Sign In
Farxiga vs. GlyxambiBerinert vs. CinryzeEmgality vs. QuliptaFarxiga vs. InvokanaFirazyr vs. SajazirGlyxambi vs. InvokanaInvokamet vs. SynjardyOpzelura vs. DupixentOrencia vs. RinvoqQulipta vs. VyeptiStelara vs. TremfyaSynjardy vs. VictozaTaltz vs. BimzelxVyepti vs. Nurtec ODTView all Comparisons
ADHD drugsAnxiety drugsAsthma drugsAtopic dermatitis drugsDepression drugsHeart failure drugsHypertension drugsLymphoma drugsOsteoarthritis drugsRheumatoid arthritis drugsRosacea drugsSchizophrenia drugsType 2 Diabetes drugsView all Indications
Bayer drugsAbbVie drugsAstraZeneca drugsEli Lilly and Company drugsGenetech drugsGlaxoSmithKline (GSK) drugsNovartis drugsPfizer drugsTakeda Pharmaceuticals drugsTeva Pharmaceuticals drugsAmgen drugsView all Manufacturers
Beta-Adrenergic BlockerAngiotensin Converting Enzyme InhibitorAngiotensin 2 Receptor BlockerCalcium Channel BlockerDiureticsHMG-CoA Reductase InhibitorProton Pump InhibitorSelective Serotonin Reuptake InhibitorNorepinephrine Reuptake InhibitorBenzodiazepinesOpioid AgonistsNonsteroidal Anti-inflammatory DrugsAntiepileptic AgentsAntipsychoticsAntihistaminesView all Classes
Wegovy®Ozempic®Mounjaro®Zepbound®Jardiance®Farxiga®Dupixent®Trulicity®Lyrica®Lipitor®Effexor®Concerta®Depakote®Trintellix®Rexulti®Rinvoq®Verzenio®Taltz®
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
PrescriberPoint
HIPAA Logo
HIPAA COMPLIANT
SOC 2 Logo
Soc 2 Type II
For ProvidersRequest DemoJoin Research Panel
Prescribing toolsPrescribing InfoCoverageSavingsPatient ResourcesA-Z IndicationsCompare Drugs
CompanyPartnershipsAboutCareersContact Us
Get the latest insights in your inbox
  • Terms and Conditions
  • Privacy Policy
  • © 2026 PrescriberPoint. All Rights Reserved.
    1. Home
    2. Indications
    3. Colorectal Neoplasms

    Medications for Colorectal Neoplasms

    FiltersReset Filters
    12 results

    • capecitabine

      (Capecitabine)
      Areva Pharmaceuticals
      Usage: Capecitabine is indicated for adjuvant treatment of Dukes’ C colon cancer post-surgery and as a first-line treatment for metastatic colorectal carcinoma. It is also used with docetaxel for metastatic breast cancer after prior anthracycline failure and as monotherapy for resistant metastatic breast cancer.

    • capecitabine

      (capecitabine)
      BluePoint Laboratories
      Usage: Capecitabine is indicated for the treatment of various cancers, including Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, and unresectable or metastatic gastric and pancreatic cancers, often in combination with other chemotherapy agents.

    • capecitabine

      (CAPECITABINE)
      NorthStar RxLLC
      Usage: Capecitabine is indicated for adjuvant treatment of Dukes' C colon cancer post-surgery and as first-line therapy for metastatic colorectal carcinoma. It is also used in combination with docetaxel for metastatic breast cancer after anthracycline failure, or as monotherapy for patients resistant to paclitaxel and anthracyclines.

    • capecitabine

      (Capecitabine)
      Aurobindo Pharma Limited
      Usage: Capecitabine tablets are indicated for the treatment of Stage III colon cancer, locally advanced rectal cancer, unresectable or metastatic colorectal cancer, advanced or metastatic breast cancer, unresectable gastric or esophageal cancers, and as adjuvant therapy for pancreatic adenocarcinoma in combination with chemotherapy regimens.

    • capecitabine 150mg

      (Capecitabine)
      Armas Pharmaceuticals Inc.
      Usage: Capecitabine tablets are indicated for adjuvant treatment of Dukes' C colon cancer post-surgery and as first-line therapy for metastatic colorectal carcinoma. They are also used for metastatic breast cancer after anthracycline failure, both in combination with docetaxel and as monotherapy for resistant cases.

    • cyramza

      (ramucirumab)
      Eli Lilly and Company
      Usage: CYRAMZA is indicated for treating advanced or metastatic gastric/gastro-esophageal junction cancer, non-small cell lung cancer (NSCLC), colorectal cancer, and hepatocellular carcinoma in specific patient populations following prior treatments with chemotherapy or targeted therapies. It can be used alone or in combination with other agents.

    • leucovorin calcium

      (leucovorin calcium)
      Slate Run Pharmaceuticals, LLC
      Usage: Leucovorin calcium is indicated for rescue after high-dose methotrexate therapy in osteosarcoma, to reduce toxicity from methotrexate overdosage, treat megaloblastic anemia due to folic acid deficiency, and as an adjunct with 5-fluorouracil in palliative treatment of advanced colorectal cancer.

    • leucovorin calcium

      (leucovorin calcium)
      Sagent Pharmaceuticals
      Usage: Leucovorin calcium is indicated as a rescue therapy after high-dose methotrexate in osteosarcoma, to reduce toxicity from methotrexate or folic acid antagonist overdosage, treat megaloblastic anemias, and enhance survival in advanced colorectal cancer when used with 5-fluorouracil (separate infusions needed).

    • oxaliplatin

      (Oxaliplatin)
      Ingenus Pharmaceuticals, LLC
      Usage: Oxaliplatin injection, in combination with infusional fluorouracil/leucovorin, is indicated for the adjuvant treatment of Stage III colon cancer post-surgery and for the treatment of advanced colorectal cancer.

    • oxaliplatin

      (Oxaliplatin)
      Sandoz Inc
      Usage: Oxaliplatin injection, combined with infusional fluorouracil and leucovorin, is indicated for the adjuvant treatment of stage III colon cancer post-complete tumor resection and for the treatment of advanced colorectal cancer.